FindTrial
Sign In

Assessment of drug-related issues among chronic liver disease patients at a tertiary care hospital

ASSESSMENT OF DRUG RELATED PROBLEMS AMONG THE PATIENTS OF CHRONIC LIVER DISEASE IN A TERTIARY CARE HOSPITAL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047165
Enrollment
150
Registered
2022-11-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K768- Other specified diseases of liver

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants of either gender above 18 years of age diagnosed with chronic liver disease 2. Inpatients and outpatients diagnosed with chronic liver disease

Exclusion criteria

Exclusion criteria: 1. Participants admitted in ICU. 2. Participants who are not willing to give consent.

Design outcomes

Primary

MeasureTime frame
To assess various drug related problems in patients with chronic liver disease.Timepoint: 4 weeks—

Secondary

MeasureTime frame
To determine the cause associated with drug related problemsTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr Adithi Kellarai

NGSM Institute of Pharmaceutical Sciences, NITTE (Deemed to be university)

junojoel@nitte.edu.in9480470727

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026